Naturally Occurring Antibodies That Recognize Linear Epitopes in the Amino Terminus of the Hepatitis C Virus E2 Protein Confer Noninterfering, Additive Neutralization

被引:55
|
作者
Tarr, Alexander W. [1 ,2 ]
Urbanowicz, Richard A. [1 ,2 ]
Jayaraj, Dhanya [1 ,2 ]
Brown, Richard J. P. [1 ,2 ]
McKeating, Jane A. [3 ]
Irving, William L. [1 ,2 ]
Ball, Jonathan K. [1 ,2 ]
机构
[1] Univ Nottingham, Queens Med Ctr, Sch Mol Med Sci, Nottingham NG7 2RD, England
[2] Univ Nottingham, Queens Med Ctr, Nottingham Digest Dis Ctr, Biomed Res Unit, Nottingham NG7 2RD, England
[3] Univ Birmingham, Inst Biomed Res, Birmingham, W Midlands, England
基金
英国医学研究理事会;
关键词
LIVER-TRANSPLANT RECIPIENTS; HUMAN MONOCLONAL-ANTIBODIES; SCAVENGER RECEPTOR BI; TO-CELL TRANSMISSION; ENVELOPE GLYCOPROTEIN; CD81; BINDING; CHRONIC INFECTION; VIRAL ENTRY; GENOTYPES; PARTICLES;
D O I
10.1128/JVI.06492-11
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Chronic hepatitis C virus (HCV) infection can persist even in the presence of a broadly neutralizing antibody response. Various mechanisms that underpin viral persistence have been proposed, and one of the most recently proposed mechanisms is the presence of interfering antibodies that negate neutralizing responses. Specifically, it has been proposed that antibodies targeting broadly neutralizing epitopes located within a region of E2 encompassing residues 412 to 423 can be inhibited by nonneutralizing antibodies binding to a less conserved region encompassing residues 434 to 446. To investigate this phenomenon, we characterized the neutralizing and inhibitory effects of human-derived affinity-purified immunoglobulin fractions and murine monoclonal antibodies and show that antibodies to both regions neutralize HCV pseudoparticle (HCVpp) and cell culture-infectious virus (HCVcc) infection albeit with different breadths and potencies. Epitope mapping revealed the presence of overlapping but distinct epitopes in both regions, which may explain the observed differences in neutralizing phenotypes. Crucially, we failed to demonstrate any inhibition between these two groups of antibodies, suggesting that interference by nonneutralizing antibodies, at least for the region encompassing residues 434 to 446, does not provide a mechanism for HCV persistence in chronically infected individuals.
引用
收藏
页码:2739 / 2749
页数:11
相关论文
共 50 条
  • [1] Hepatitis C virus with a naturally occurring single amino-acid substitution in the E2 envelope protein escapes neutralization by naturally-induced and vaccine-induced antibodies
    Duan, Hongying
    Struble, Evi
    Zhong, Lilin
    Mihalik, Kathleen
    Major, Marian
    Zhang, Pei
    Feinstone, Stephen
    Feigelstock, Dino
    VACCINE, 2010, 28 (25) : 4138 - 4144
  • [2] Cooperativity in Virus Neutralization by Human Monoclonal Antibodies to Two Adjacent Regions Located at the Amino Terminus of Hepatitis C Virus E2 Glycoprotein
    Keck, Zhenyong
    Wang, Wenyan
    Wang, Yong
    Lau, Patrick
    Carlsen, Thomas H. R.
    Prentoe, Jannick
    Xia, Jinming
    Patel, Arvind H.
    Bukh, Jens
    Foung, Steven K. H.
    JOURNAL OF VIROLOGY, 2013, 87 (01) : 37 - 51
  • [3] Amino Acid Residue-Specific Neutralization and Nonneutralization of Hepatitis C Virus by Monoclonal Antibodies to the E2 Protein
    Duan, Hongying
    Kachko, Alla
    Zhong, Lilin
    Struble, Evi
    Pandey, Shivani
    Yan, Hailing
    Harman, Christine
    Virata-Theimer, Maria Luisa
    Deng, Lu
    Zhao, Zhong
    Major, Marian
    Feinstone, Stephen
    Zhang, Pei
    JOURNAL OF VIROLOGY, 2012, 86 (23) : 12686 - 12694
  • [4] Human monoclonal antibodies that inhibit binding of hepatitis C virus E2 protein to CD81 and recognize conserved conformational epitopes
    Hadlock, KG
    Lanford, RE
    Perkins, S
    Rowe, J
    Yang, Q
    Levy, S
    Pileri, P
    Abrignani, S
    Foung, SKH
    JOURNAL OF VIROLOGY, 2000, 74 (22) : 10407 - 10416
  • [5] Human monoclonal antibodies to conserved conformational epitopes within hepatitis C virus E2 protein.
    Hadlock, KG
    Yang, Q
    Rowe, J
    Perkins, S
    Lanford, R
    Foung, SKH
    HEPATOLOGY, 1998, 28 (04) : 275A - 275A
  • [6] Anti-hepatitis C virus E2 (HCV/E2) glycoprotein monoclonal antibodies and neutralization interference
    Sautto, Giuseppe
    Mancini, Nicasio
    Diotti, Roberta A.
    Solforosi, Laura
    Clementi, Massimo
    Burioni, Roberto
    ANTIVIRAL RESEARCH, 2012, 96 (01) : 82 - 89
  • [7] Structural and Antigenic Definition of Hepatitis C Virus E2 Glycoprotein Epitopes Targeted by Monoclonal Antibodies
    Sautto, Giuseppe
    Tarr, Alexander W.
    Mancini, Nicasio
    Clementi, Andmassimo
    CLINICAL & DEVELOPMENTAL IMMUNOLOGY, 2013,
  • [8] Directing the natural catalytic activity of antibodies to hepatitis C virus E2 protein
    Sapparapu, Gopal
    Planque, Stephanie A.
    Wang, Runsheng
    Nishiyama, Yasuhiro
    Keck, Zhen-Yong
    Foung, Steven
    Paul, Sudhir
    JOURNAL OF IMMUNOLOGY, 2007, 178
  • [9] Naturally Occurring Mutations in Hepatitis C Virus E2 Conferring Resistance to Multiple Broadly Neutralizing Monoclonal Antibodies Identified by a Novel Method
    Bailey, Justin R.
    Snider, Anna E.
    Osburn, William O.
    Ray, Stuart C.
    HEPATOLOGY, 2013, 58 : 927A - 927A
  • [10] Neutralizing Monoclonal Antibodies against Hepatitis C Virus E2 Protein Bind Discontinuous Epitopes and Inhibit Infection at a Postattachment Step
    Sabo, Michelle C.
    Luca, Vincent C.
    Prentoe, Jannick
    Hopcraft, Sharon E.
    Blight, Keril J.
    Yi, MinKyung
    Lemon, Stanley M.
    Ball, Jonathan K.
    Bukh, Jens
    Evans, Matthew J.
    Fremont, Daved H.
    Diamond, Michael S.
    JOURNAL OF VIROLOGY, 2011, 85 (14) : 7005 - 7019